?
Stuffing money under the sofa, while not as sexy, may prove more profitable going forward, with?Mattress Firm Holding?(MFRM) advancing a further 1.82% to a post-IPO peak -- even if more of us opt to?freeze, rather than sleep on, our assets. In analyst action, an upgrade?of?Vornado Realty Trust?(VNO) sent it 2.76% higher to pace all S&P 500 (GSPC) gainers. This company owns Two Penn Plaza, which is?a stone?s throw?from Madison Square Garden (MSG), and owners of the latter may wish to take out their frustration by testing the distance literally after a ratings reduction sent it skidding 1.54%. Elsewhere Brent crude oil fell to $118.20 per barrel, an almost two-month low, after Iranian nuclear talks began auspiciously -- alas, not before the?Barbie-banning ayatollahs?extracted an horrific price on its parent?Mattel?(MAT), which nosedived 9.14% as the iconic doll posted its first sales decline in ten quarters. And on a day a?rapping medic with no prior experience on Wall Street?was elected the twelfth president of the World Bank, it was announced that there would be?no winner of the Pulitzer Prize for fiction. With fact so endlessly fantastical, who needs fantasy? It?s a torrid Tuesday on the earnings front, with Coca-Cola (KO), Goldman Sachs (GS), Intel (INTC), International Business Machines (IBM), Johnson & Johnson (JNJ), and Yahoo (YHOO) among a multitude of companies due to report results.
?
Initiations:
?
Apple Inc. (AAPL): Can?t keep the company out of the news. Shares are rebounding in the pre-market on a Strong Buy coverage roll out at Raymond James, whose price objective is a relatively restrained $800.
?
Tiffany & Co. (TIF): The luxury jeweler is a new Neutral at Macquarie.
?
Investment banks: Susquehanna resumes?Raymond James Financial?(RJF) with a Positive. It has new Neutrals on?Jefferies?(JEF) and?Greenhill?(GHL), and launches LPL Investment?(LPLA) and?Lazard?(LAZ) with Negatives on each, assigning a $21 target price on the latter.
?
Health care industry: Auriga establishes Buys on both?Sagent Pharmaceuticals (SGNT) and?Impax Labs?(IPXL), rolling out respective price objectives of $22 and $30. It has a Hold, and $16 target, on?Warner Chilcott?(WCRX).
?
Biotechs:?Achillion Pharmaceuticals?(ACHN) and?Vertex Pharmaceuticals (VRTX) are each assumed with Outperforms at Credit Suisse.
?
Cameco?(CCJ): JPMorgan has an Overweight on CCJ.
?
Cerus Corp?(CERS): Cantor Fitzgerald begins Buy rated coverage of the small cap stock, assigning it a $5.50 price target. The broker believes that CERS?s pathogen inactivation technology will eventually become standard of care in this $6 billion global market.
?
Fossil?(FOSL): Macquarie has a fresh Outperform on FOSL.
?
Nationstar Mortgage?(NSM): Keefe Bruyette covers the company at Outperform.
?
Laredo Petroleum?(LPI): BMO Capital launches Outperform coverage on LPI.
?
Select Income REIT?(SIR): SIR is started at a Market Perform with Wells Fargo.
?
Rollins Inc. (ROL): Shares are a Hold at KeyBanc Capital.
?
Qualcomm?(QCOM): The tech company is picked up at Outperform with Raymond James.
?
?
Upgrades:
?
Travelers?(TRV): The property and casualty insurance outfit, yesterday?s top Dow stock, is today taken to Equal Weight from Underweight at Evercore.
?
Trina Solar?(TSL): Auriga ups its rating to Buy from Hold, sending shares up sharply before the opening bell.
?
Teekay Tankers?(TNK): Bank of America-Merrill Lynch lifts TNK to Neutral from Underperform.
?
Terex?(TEX): TEX is moved to Outperform from Market Perform with Wells.
?
SAP AG?(SAP): The German software giant, downgraded elsewhere this morning, is also boosted to Buy from Hold at Soci?t? G?n?rale.
?
AutoNation?(AN): Wells Fargo raises AN to Market Perform from Underperform.
?
Energy stocks:?Oasis Petroleum?(OAS) and?Newfield Exploration?(NFX) both get Buy-from-Hold boosts at Jefferies.
?
Energy stocks:?GenOn Energy?(GEN) is hoisted to Hold from Sell by Deutsche Bank, where?NRG Energy?(NRG) is now Buy from Hold.
?
ENI S.p.A.?(E): Jefferies juices the Italian oil and gas firm to Buy from Hold.
?
ING Groep?(ING): ING is now Neutral from Underperform at Exane BNP Paribas.
?
?
Downgrades:
?
First Solar?(FSLR): With news just breaking that FSLR is to cut 30% of its workforce, the firm gets downgraded to Neutral from Buy at Goldman Sachs.
?
Cabela?s?(CAB): The hunting and shooting retailer is cut to Hold from Buy with a $40 objective at Feltl & Co, which cites valuation issues.
?
Celestica?(CLS): Shares are lower ahead of the open on a downgrade to Hold from Buy at Deutsche Bank.
?
CSX Corp?(CSX): The railroad company gets cut to Hold from Buy at Argus, which believes the risk to profit growth over the near-term has increased due to continued weakness in its coal business.
?
YPF Sociedad Anonima?(YPF): The just-nationalized Argentine energy behemoth, trading at a fresh trough, is lowered to Underperform from Neutral by Bank of America-Merrill Lynch and Underperform from Neutral at Credit Suisse. Speaking of which...
?
Repsol SA?(REPYY): The Spanish firm, whose head has claimed Argentine President Cristina Fernandez ?carried out an unlawful act? in authorizing the YPF takeover, is itself cut to Hold from Buy by both Jefferies and Deutsche Bank. Shares are slumping in European trading this morning as a result.
?
Remy Cointreau?(REMYF): France?s Cognac king is cut to Neutral from Outperform by BNP Paribas
?
SAP AG?(SAP): The German software giant gets downgraded to Neutral from Overweight at HSBC Securities, whose concerns include execution issues in North America.
?
Synaptics?(SYNA): Shares are now Neutral from Buy at Mizuho, which trims its target by $2 to $35.
?
Progress Energy?(PGN): Barclays cuts the stock to Equal Weight from Overweight.
?
Infosys?(INFY): Goldman gives the recently-slumping Indian outsourcer a Neutral-from-Buy ratings reduction.
?
Insurance stocks: Evercore cuts?Chubb?(CB),?W.R. Berkley?(WRB), and?Arch Capital?(ACGL), all now Equal-Weight from Overweight.
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
matt bomer westminster kennel club dog show jeremy lin game winner chocolate covered strawberries shrimp scampi kate upton si cover lobster recipes
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.